Cardinal Health IncCAH
▲ PositiveCapitalrelevance
Q2 EPS beat and raised FY2027 guidance above consensus.

Cardinal Health reported second quarter adjusted earnings per share of $2.60, beating analyst estimates of $2.42, while revenue of $63.67 billion fell short of the $65.42 billion consensus. The company issued adjusted EPS guidance for fiscal 2027 of $12.50 at the midpoint, above analyst expectations by 3.5%. CFO Aaron Alt attributed the profit strength to strong demand and execution in the Pharmaceutical and Specialty Solutions segment, while CEO Jason Hollar highlighted double-digit specialty growth and synergy realization from recent acquisitions. Management also addressed regulatory changes, generic conversions, and input cost pressures during the earnings call.
Cardinal Health IncQ2 EPS beat and raised FY2027 guidance above consensus.